RIZMOIC Trademark

Trademark Overview

On Monday, April 18, 2016, a trademark application was filed for RIZMOIC with the United States Patent and Trademark Office. The USPTO has given the RIZMOIC trademark a serial number of 87003973. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2019. This trademark is owned by Shionogi & Co., Ltd.. The RIZMOIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating opioid-induced constipation, pharmaceutical preparations for use in the treatment and prevention of opioid-induced gastrointestinal adverse effects
rizmoic

General Information

Serial Number87003973
Word MarkRIZMOIC
Filing DateMonday, April 18, 2016
Status700 - REGISTERED
Status DateTuesday, March 5, 2019
Registration Number5688465
Registration DateTuesday, March 5, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating opioid-induced constipation, pharmaceutical preparations for use in the treatment and prevention of opioid-induced gastrointestinal adverse effects

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 21, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShionogi & Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP
Party NameShionogi & Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP
Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP

Trademark Events

Event DateEvent Description
Tuesday, March 5, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, January 29, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, December 13, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 13, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, April 12, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 12, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 20, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 18, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 18, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 18, 2016LETTER OF SUSPENSION E-MAILED
Friday, November 18, 2016SUSPENSION LETTER WRITTEN
Wednesday, November 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 26, 2016ASSIGNED TO LIE
Tuesday, October 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2016NON-FINAL ACTION WRITTEN
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Thursday, April 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2016NEW APPLICATION ENTERED

Related Keywords

rizmoic pharmaceutical induced opioid preparations adverse effects gastrointestinal constipation treating treatment